Covalon Technologies Ltd. (COV) - Total Liabilities
Based on the latest financial reports, Covalon Technologies Ltd. (COV) has total liabilities worth CA$6.41 Million CAD (≈ $4.64 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Covalon Technologies Ltd. (COV) equity growth momentum to track the company's year-over-year net asset growth rate.
Covalon Technologies Ltd. - Total Liabilities Trend (2005–2025)
This chart illustrates how Covalon Technologies Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Covalon Technologies Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Covalon Technologies Ltd. Competitors by Total Liabilities
The table below lists competitors of Covalon Technologies Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Libental
TA:LBTL
|
Israel | ILA103.35 Million |
|
ICD Co. Ltd
KQ:040910
|
Korea | ₩45.92 Billion |
|
Metalpha Technology Holding Limited
NASDAQ:MATH
|
USA | $378.71 Million |
|
Pacgold Ltd
AU:PGO
|
Australia | AU$4.89 Million |
|
ALANDEQGRP FPO
AU:AEG
|
Australia | AU$3.09 Million |
|
Claranova SE
PA:CLA
|
France | €96.30 Million |
|
Ashmore Asset Management Indonesia
JK:AMOR
|
Indonesia | Rp88.92 Billion |
|
GenMont Biotech Inc
TW:3164
|
Taiwan | NT$297.05 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down Covalon Technologies Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see COV market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Covalon Technologies Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Covalon Technologies Ltd. (2005–2025)
The table below shows the annual total liabilities of Covalon Technologies Ltd. from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | CA$5.40 Million ≈ $3.90 Million |
+25.45% |
| 2024-09-30 | CA$4.30 Million ≈ $3.11 Million |
-29.57% |
| 2023-09-30 | CA$6.11 Million ≈ $4.42 Million |
-0.68% |
| 2022-09-30 | CA$6.15 Million ≈ $4.45 Million |
-14.68% |
| 2021-09-30 | CA$7.21 Million ≈ $5.21 Million |
-71.83% |
| 2020-09-30 | CA$25.59 Million ≈ $18.51 Million |
+3.70% |
| 2019-09-30 | CA$24.68 Million ≈ $17.85 Million |
+274.85% |
| 2018-09-30 | CA$6.58 Million ≈ $4.76 Million |
+120.47% |
| 2017-09-30 | CA$2.99 Million ≈ $2.16 Million |
+11.38% |
| 2016-09-30 | CA$2.68 Million ≈ $1.94 Million |
-5.76% |
| 2015-09-30 | CA$2.84 Million ≈ $2.06 Million |
+16.88% |
| 2014-09-30 | CA$2.43 Million ≈ $1.76 Million |
-10.65% |
| 2013-09-30 | CA$2.72 Million ≈ $1.97 Million |
-0.19% |
| 2012-09-30 | CA$2.73 Million ≈ $1.97 Million |
+18.31% |
| 2011-09-30 | CA$2.31 Million ≈ $1.67 Million |
-16.10% |
| 2010-09-30 | CA$2.75 Million ≈ $1.99 Million |
+42.76% |
| 2009-09-30 | CA$1.93 Million ≈ $1.39 Million |
-15.43% |
| 2008-09-30 | CA$2.28 Million ≈ $1.65 Million |
-14.10% |
| 2007-09-30 | CA$2.65 Million ≈ $1.92 Million |
+402.67% |
| 2006-09-30 | CA$527.43K ≈ $381.54K |
-25.49% |
| 2005-09-30 | CA$707.83K ≈ $512.03K |
-- |
About Covalon Technologies Ltd.
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more